Deciphera to be acquired by Ono Pharmaceutical for $25.60/share in cash, ~$2.4B equity value

ion (the “ Company ” or “ Deciphera ”), Ono Pharmaceutical Co., Ltd., a Japanese company ( kabushiki kaishi ) (“ Parent ” or “ Ono ”), and Topaz Merger Sub, Inc., a Delaware corporation and a wholly owned subsidiary of Parent (“ Merger Sub ”), entered into an Agreement and Plan of Merger (the “ Merger Agreement ”). Pursuant to the Merger Agreement, and upon the terms and subject to the conditions therein, Merger Sub will commence a cash tender offer (the “ Offer ”) to acquire all of the issued and outstanding shares of the common stock, par value $0.01 per share, of the Company (“ Company Common Stock ”), at a price per share of $25.60, net to the seller in cash, without interest and subject to any withholding of taxes required by applicable law.